Abstract
Epstein-Barr virus (EBV)-positive gastric adenocarcinoma exhibits locally intense inflammation but systemic manifestations are uncertain. Our study examined whether circulating mediators of inflammation and immune response differ by tumor EBV status. From a Latvian series of 302 gastric cancer cases, we measured plasma levels of 92 immune-related proteins in the 28 patients with EBV-positive tumors and 34 patients with EBV-negative tumors. Eight markers were statistically significantly higher with tumor EBV positivity: chemokine C-C motif ligand (CCL) 20 (Odds Ratio (OR) = 3.6; p-trend = 0.001), chemokine C-X-C motif ligand 9 (OR = 3.6; p-trend = 0.003), programmed death-ligand 1 (PD-L1; OR = 3.4; p-trend = 0.004), interleukin (IL)-10 (OR = 2.4; p-trend = 0.019), CCL19 (OR = 2.3; p-trend = 0.019), CCL11 (OR = 2.2; p-trend = 0.026), IL-17A (OR = 2.0; p-trend = 0.038) and CCL8 (OR = 1.9; p-trend = 0.049). Systemic responses to EBV-positive gastric cancer are characterized by alterations in chemokines and PD-L1. Profiling of these molecules may enable non-invasive diagnosis of EBV status when tumor tissue is unavailable. Our findings provide theoretical justification for clinical evaluations of immune checkpoint therapy for EBV-po...Continue Reading
References
Jul 20, 1999·The Journal of Clinical Investigation·K KuzushimaT Tsurumi
Feb 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Josine van BeekElisabeth Bloemena
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kai-Ping ChangJau-Song Yu
Nov 13, 2008·Laboratory Investigation; a Journal of Technical Methods and Pathology·Julie L RyanMargaret L Gulley
May 6, 2011·Journal of Virology·Chien-Hsun LeeYao Chang
May 12, 2011·Head & Neck·Kai-Ping ChangJau-Song Yu
Jan 18, 2012·Seminars in Cancer Biology·Claire GourzonesPierre Busson
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Nov 28, 2013·PloS One·Li-Jen HsinKai-Ping Chang
Apr 24, 2014·PloS One·Erika AssarssonSimon Fredriksson
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Nov 2, 2014·Oncotarget·Wenfeng FangLi Zhang
Apr 15, 2015·Viral Immunology·Elias A RahalAlexander M Abdelnoor
Oct 30, 2016·Virology·Ryan IncrocciMichelle Swanson-Mungerson
Citations
Sep 6, 2019·Helicobacter·M Constanza CamargoJose C Machado
Mar 4, 2020·Oncogene·Yanan ZhaoWei Kang
Nov 14, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·M Constanza CamargoCharles S Rabkin
Jul 25, 2020·Gastroenterology·Robert J HuangUNKNOWN Summit Leaders